Stay up-to-date with the latest news, articles, and industry insights from VigiLanz.
Q&A: Sharp HealthCare’s Commitment to, and Experience With, Clinical Trials
Five questions for DeAnn Cary, PhD, Director of Research at Sharp HealthCare
VigiLanz Announces Launch of New Clinical Trial Patient Identification Solution
By automating the patient identification process, VigiLanz Research will provide help for clinical trial sites seeking to accelerate patient recruitment, meet time-sensitive enrollment targets, and gain insights on patients screened for eligibility.